Offset Analgesia as a Measure of Central Sensitization in Children
NCT03445403 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15
Last updated 2021-02-21
Summary
Pediatric chronic pain disorders are common and consequential in Western societies, occurring in 25-80% of population-based samples with a median prevalence of 11-38% and significant pain-related disability in 3-5% of these children. Pediatric chronic pain disorders have a negative impact on many aspects children's lives including mobility, night sleep, school attendance, peer relationships, family functioning, and overall quality of life. Parents caring for these children risk loss of parental earnings, and these disorders place a high financial burden on healthcare. In a nationally representative sample in the United States, costs related to health care were significantly higher ($1,339 per capita) for children with chronic pain disorders compared to children with common pediatric health conditions of ADHD, asthma and obesity.
In children with clinical chronic pain conditions, such as daily headaches or fibromyalgia, chronic pain is presumably a persistent state of an overly excitable nervous system. This phenomenon known as central sensitization is characterized by excessive pain sensitivity that occurs in response to non-painful stimuli, such as light touch or contact with clothing, and slightly painful stimuli, such as a light pinprick. This hypersensitivity results from peculiar changes in the working of the central nervous system, including the spinal cord and brain, and leads to unusual intensification of pain that is out of proportion to the inciting stimulus. For example, light touch from clothing on the skin is perceived as intensely painful. Central sensitization is also thought to contribute to the spreading of pain to other body sites in several chronic pain disorders.
In chronic pain disorders, the function of the central descending inhibitory modulating system is likely impaired and is traditionally measured by a phenomenon identified as "conditioned pain modulation (CPM)" and more recently measured by a phenomenon of "offset analgesia" (OA). The OA test is more robust than the CPM test and likely more acceptable to most patients, especially children, because it is shorter in duration and uses a more tolerable painful stimulus. Compared to CPM, the OA test is more tolerable because it is conducted using a painful test stimulus that is less than the maximal (suprathreshold). Additionally, the time of exposure to the painful stimulus is significantly shorter, a few seconds, in the OA test compared to CPM.
The central descending inhibitory pathway that modulates pain as tested by OA is functional and mature in healthy children as young as 6 year of age, but it has yet to be investigated in children with chronic pain disorders. The investigators plan to test OA responses in a population of common pediatric pain disorders with overlapping symptomology attributed to central sensitization (such as chronic musculoskeletal pain, chronic abdominal pain and chronic headaches and chronic regional pain syndromes) and compare their responses with an age- and sex-matched control group. The characteristics of OA responses in each group will allow for assessment of the presence or absence of central sensitization as a mechanism driving the persistent, abnormal pain in a subgroup of these chronic pain disorders. The investigators hypothesize that central sensitization is the potential contributory mechanism of the central nervous system heightened sensitivity to two testing stimuli of painful (moderate heat discomfort sensation) and non-painful (warmth sensation) in children with chronic pain disorders. These types of sensations mimic those that children would be expected to experience their natural environment during typical activities of daily living such as showering/bathing in warm water or hand washing.
Additionally, the Pain Sensitivity Questionnaire (PSQ) and Central Sensitization Inventory (CSI) will be used as clinical screening tools for subjective report of sensitization symptoms, and are simple and easy to administer in a clinical setting. The investigators hypothesize that these measures will correlate with the objective offset analgesia responses thus allowing for assessment of central sensitization in children with chronic pain disorders.
These tests are advantageous because they are feasible to perform rapidly in a clinic setting and have utility for measurement of patient responses to therapeutic interventions. If this concept is supported by this study, future studies could utilize OA to examine the effects of various pharmacological and physical interventions used to manage children with chronic pain disorders including intensive interdisciplinary rehabilitation or specific interventions such as aerobic exercise, which likely modulates pain via similar mechanisms.
Conditions
- Chronic Pain Syndrome
- Chronic Daily Headache
- Functional Abdominal Pain Syndrome
- Musculoskeletal Pain Disorder
- CRPS (Complex Regional Pain Syndromes)
Interventions
- OTHER
-
Offset analgesia
Exposure to a moderate heat-pain stimulus applied for 5 seconds, raised by 1 degree C for 5 seconds, reduced by 1 degree C, and held for 20 seconds using a computerized paradigm in order to evoke endogenous pain modulation.
Sponsors & Collaborators
- lead OTHER
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- SCREENING
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 10 Years
- Max Age
- 17 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2018-04-01
- Primary Completion
- 2019-12-27
- Completion
- 2020-12-01
Countries
- United States
Study Locations
More Related Trials
-
Low Dose Ketamine Study on Opioid Tolerance and Hyperalgesia
NCT01325493 ·Status: COMPLETED ·Phase: PHASE4
-
Abdominal Pain Disorders Functional in Children: Impact of Hypno-analgesia on the Autonomic Balance
NCT02830698 ·Status: TERMINATED
-
Treatment Options for Pediatric Chronic Pain: How do we Best Disseminate Our Scientific Findings
NCT05239299 ·Status: COMPLETED
-
Remifentanil in Children With Obstructive Sleep Apnea
NCT03958396 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
Randomized, Double-blind, Placebo, Controlled Cross Over Design Topical Morphine for Analgesia in Pediatric Procedures
NCT02300194 ·Status: WITHDRAWN ·Phase: PHASE4
-
Pain Management of Children With Appendicitis in the Emergency Department (ER)
NCT03075293 ·Status: UNKNOWN
-
Opioid Laws and Pediatric Use
NCT04543227 ·Status: COMPLETED
-
Neuropathic Pain in Children: Multimodal Assessment and Diagnosis
NCT03312881 ·Status: COMPLETED
-
Observational Study of the Use of 8% Capsaicin Patch in Children 0 to 18 Years Old
NCT05299294 ·Status: RECRUITING
-
Post Operative Pain Control After Pediatric Hip Surgery
NCT03435692 ·Status: TERMINATED ·Phase: NA
-
Analgesic Efficacy of Repeated Doses of Intravenous (IV) Acetaminophen in Post-operative Pediatric Spine Fusion Patients
NCT01394718 ·Status: COMPLETED ·Phase: PHASE3
-
Population Pharmacokinetics and Pharmacogenomics of Oral Oxycodone in Pediatric Surgical Patients
NCT02044497 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Oral Ketamine for Control of Chronic Pain in Children
NCT01369680 ·Status: COMPLETED ·Phase: PHASE1
-
Optimizing Pain Treatment in Children On Mechanical Ventilation
NCT06994442 ·Status: RECRUITING ·Phase: PHASE3
-
Initial Pain Management in Pediatric Pancreatitis: Opioid vs. Non-Opioid
NCT04291599 ·Status: TERMINATED ·Phase: PHASE2
-
Cold Therapy for Pediatric Appendectomy
NCT04986397 ·Status: COMPLETED ·Phase: NA
-
Double Blind Randomized Study Into the Efficacy of Codeine Phosphate Analgesia After Cleft Palate Repair in Infants
NCT00386269 ·Status: COMPLETED ·Phase: PHASE4
-
Effect of Early Morphine Administration on the Development of Acute Opioid Tolerance During Pediatric Scoliosis Surgery
NCT00737997 ·Status: COMPLETED ·Phase: PHASE3
-
Morphine or Ketamine for Analgesia
NCT06835504 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Use of Tapentadol Oral Solution for Pain After Surgery in Children From Newborn to Less Than 2 Years Old
NCT02221674 ·Status: TERMINATED ·Phase: PHASE2
-
Parental Blinding in Clinical Trials of Osteopathy
NCT02511171 ·Status: UNKNOWN ·Phase: NA
-
Safety of Twice Daily Oxycodone Hydrochloride Controlled-release Tablets in Children With Moderate to Severe Malignant and/ or Nonmalignant Pain Requiring Opioids
NCT01192295 ·Status: COMPLETED ·Phase: PHASE3
-
Ketamine and Postoperative Analgesia in Children
NCT00200564 ·Status: UNKNOWN ·Phase: PHASE4
-
A Multi-Center Study of the Efficacy, Pharmacokinetics (PK) and Pharmacodynamics (PD) of IV Acetaminophen for the Treatment of Acute Pain in Pediatric Patients
NCT01635101 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of Chlorpromazine or Pentobarbital Premedications for Pediatric Imaging Procedures
NCT04350528 ·Status: UNKNOWN